Scribd Logo
Upload

Welcome to Scribd!

  • 180 views

    Pfizer-BioNTech COVID-19 Vaccine Suspension For Intramuscular Injection EY0584

    Uploaded by

    Dayang Zakiah
    This compliance statement certifies that a lot of 400,140 doses of the Pfizer-BioNTech COVID-19 vaccine produced by Pharmacia & Upjohn Company meets the same quality standards as the COMIRNATY vaccine registered in Malaysia. The statement is based on an assessment of the vaccine lot's ability to maintain its cold chain requirements, and certifies the lot number, expiry date, number of doses, and number of doses per container.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Pfizer-BioNTech COVID-19 Vaccine Suspension For Intramuscular Injection EY0584

    Uploaded by

    Dayang Zakiah
    180 views1 page
    This compliance statement certifies that a lot of 400,140 doses of the Pfizer-BioNTech COVID-19 vaccine produced by Pharmacia & Upjohn Company meets the same quality standards as the COMIRNATY vaccine registered in Malaysia. The statement is based on an assessment of the vaccine lot's ability to maintain its cold chain requirements, and certifies the lot number, expiry date, number of doses, and number of doses per container.

    Original Title

    Pfizer-BioNTech_COVID-19_Vaccine_Suspension_for_Intramuscular_Injection_EY0584

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This compliance statement certifies that a lot of 400,140 doses of the Pfizer-BioNTech COVID-19 vaccine produced by Pharmacia & Upjohn Company meets the same quality standards as the COMIRNATY vaccine registered in Malaysia. The statement is based on an assessment of the vaccine lot's ability to maintain its cold chain requirements, and certifies the lot number, expiry date, number of doses, and number of doses per container.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    180 views1 page

    Pfizer-BioNTech COVID-19 Vaccine Suspension For Intramuscular Injection EY0584

    Uploaded by

    Dayang Zakiah
    This compliance statement certifies that a lot of 400,140 doses of the Pfizer-BioNTech COVID-19 vaccine produced by Pharmacia & Upjohn Company meets the same quality standards as the COMIRNATY vaccine registered in Malaysia. The statement is based on an assessment of the vaccine lot's ability to maintain its cold chain requirements, and certifies the lot number, expiry date, number of doses, and number of doses per container.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    COMPLIANCE STATEMENT FOR RELEASE

    The following lot of Pfizer-BioNTech COVID-19 Vaccine Suspension for


    Intramuscular Injection (with 2mL diluent – 0.9% Sodium Chloride Injection,
    USP) (mRNA vaccine – nucleoside modified) produced by Pharmacia & Upjohn
    Company LLS, Kalamazoo Michigan, USA, whose numbers appears on the
    labels of the final containers, is comparable and conform to the same quality
    standard as COMIRNATY Concentrate for Dispersion for Injection registered in
    Malaysia.

    As a minimum, the release is based on assessment on the cold chain


    requirement only.

    Lot no: EY0584


    Expiry date: 31 October 2021
    No. of doses: 400,140
    No. of doses per container: 6

    Signature:

    Name of authorized person: NIK JUZAIMAH BINTI JUHARI


    Head of Product and Cosmetic Testing Section
    for Director of National Pharmaceutical Regulatory Agency (NPRA)
    Ministry of Health Malaysia

    Date: 5 July 2021

    You might also like